REFERENCES
- Frishman W H, Karpenos A, Molloy T J. Cocaine-Induced Coronary Artery Disease: Recognition and Treatment. Med Clin NA 1989; 73: 475–485
- Hollander J. The management of cocaine associated myocardial ischemia. N Engl J Med 1995; 333: 1267–1272
- Cregler L L, Mark H. Medical complication of cocaine abuse. N Engl J Med 1986; 315: 1495–1499
- Wilkerson R D, Temesy-Armos P N, Fraker T D. Pharmacokinetics and time-action profile of cocaine in dogs. NIDA Res Monogr 1991; 108: 28–40
- Tracy C M, Bachenheimer L, Solomon A, et al. Evidence that cocaine slows cardiac conduction by an action on both av-nodal and his-purkinje tissue in the dog. J Electrocard 1991; 24: 257–262
- Fischman M W, Schuster C R, Javaid J, Shanano Y, Davis J. Acute tolerance development to the cardiovascular and subjective effects of cocaine. J Pharm Exp Therap 1985; 235: 677–682
- McCance-Katz E F, Price L H, McDougle C J, Kosten T R, Black J E, Jatlow P. Concurrent cocaine-ethanol ingestion in humans: Pharmacology, physiology, behavior, and the role of cocaethylene. Psychopharmacology 1993; 111: 39–46
- Holzgrefe H H, Everitt J M, Wright E M. Alpha-chloralose as a canine anesthetic. Lab Animal Sci 1987; 37: 587–594
- Van Citters R L, Franklin D L, Rushmer R F. Left ventricular dynamics in dogs during anesthesia with alpha-chloralose and sodium pentobarbital. Am J Cardiol March 1964; 349–354
- Hime G W, Hearn W L, Rose S, Cofino J. Analysis of cocaine and cocaethylene in blood and tissues by GC-NPD and GC-ion trap mass spectrometry. J Anal Toxicol 1991; 15: 241–245
- Sokall R R, Rohlf F J. Biometry. The Principles and Practices of Statistics in Biological Research. WH Freeman, San Francisco 1969; 229–364
- Bailey D N. Comprehensive review of cocaethylene and cocaine concentrations in patients. AJCP 1996; 106: 701–704
- Wetli C V, Wright R K. Death caused by recreational cocaine use. JAMA 1979; 241: 2519–2522
- Virmani R, Robinowitz M, Smialek J E, Smyth D F. Cardiovascular effects of cocaine: An autopsy study of 40 patients. Am Heart J 1988; 115: 1068–1076
- Welder A A, Grammas P, Melchert R B. Cellular mechanisms of cocaine cardiotoxicity. Tox Lett 1993; 69: 227–238
- Crumb W J, Clarkson C W. Characterization of cocaineinduced block of cardiac sodium channels. Biophys J 1990; 57: 589–599
- Crumb W J, Clarkson C W. Characterization of the sodium channel blocking properties of the major metabolites of cocaine in single cardiac myocytes. J Pharm Exp Therap 1992; 261: 910–917
- Stewart G, Rubin E, Thomas A P. Inhibition by cocaine of excitation-contraction coupling in isolated cardiomyocytes. Am J Physiol 1991; 260: H50–H57
- Thomas A P, Stewart G, McClean Bolton M, et al. Effects of ethanol and cocaine on electrically triggered calcium transients in cardiac muscle cells. Ann N Y Acad Sci 1991; 625: 395–408
- Qiu Z, Morgan J P. Differential effects of cocaine and cocaethylene on intracellular Ca2+ and myocardial contraction incardiac myocytes. Br J Pharmacol 1993; 109: 293–298
- Hale S L, Lehmann M H, Kloner R A. Electrocardiographic abnormalities after acute administration of cocaine in the rat. Am J Cardiol 1989; 63: 1529–1530
- Przywara D A, Dambach G E. Direct actions of cocaine on cardiac cellular electrical activity. Circ Res 1989; 65: 185–192
- Kimura S, Bassett A L, Xi H, Myerburg R J. Early repolarizations and triggered activity induced by cocaine: A possible mechanism of cocaine arrhythmogenesis. Circ 1992; 85: 2227–2235
- Grawe J J, Hariman R J, Winecoff A P, et al. Reversal of the electrocardiographic effects of cocaine by lidocaine. Part 2. Concentration-effect relationships. Pharmacotherapy 1994; 14: 704–711
- Cha K, Falk R H. Pulsus alternans. N Engl J Med 1996; 334: 834
- Madden J A, Powers R H. Effect of cocaine and cocaine metabolites on cerebral arteries in vitro. Life Sci 1990; 47: 1109–1114
- Brogan W C, Lange R A, Glamann D B, Hillis L D. Recurrent vasoconstriction caused by intranasal cocaine: Possible role for metabolites. Ann Int Med 1992; 116: 556–561
- Xu Y, Crumb W J, Clarkson C W. Cocaethylene, ametabolite of cocaine and ethanol, is a potent blocker of cardiac sodium channels. JPET 1994; 271: 319–325
- Henning R J, Wilson L D, Glauser J M. Cocaine plus alcohol is more cardiotoxic than cocaine or alcohol alone. Crit Care Med 1994; 22: 1896–1906
- Isner J M, Estes N A, Thompson P D, et al. Acute cardiac events temporally related to cocaine abuse. N Engl J Med 1986; 315: 1438–1443
- Fraker T D, Temesy-Armos P N, Brewster P S, Wilkerson R D. Mechanism of cocaine-induced myocardial depression in dogs. Circulation 1990; 81: 1012–1016
- Abel F L, Wilson S P, Zhao R, Fennell W H. Cocaine depresses the canine myocardium. Circ Shock 1989; 28: 309–319
- Marcos N C, Fairhurst A S, Henry W L. Direct myocardial effects of cocaine. Cardiovasc Res 1993; 27: 269–273
- Hale S L, Alker K J, Rezkalla S H, Eisenhauer A C, Kloner R A. Nifedipine protects the heart from the acute deleterious effects of cocaine if administered before but not after cocaine. Circulation 1991; 83: 1437–1443
- Nunez B D, Miao L, Yudi W, et al. Cocaine-induced microvascular spasm in yucatan miniature swine: In vivo and in vitro evidence of spasm. Circ Res 1994; 74: 281–290
- Vinulio J C, Karam R, Mekhail N, et al. Cocaine-induced small vessel spasm in isolated rat hearts. Am J Path 1989; 135: 85–91
- Sharkey J, Ritz M C, Schenden J A, et al. Cocaine inhibits muscarinic cholinergic receptors in heart and brain. J Pharm Exp Therap 1988; 246: 1048–1052
- Wang J, Carpentier R G. Electrophysiologic in-vitro effects of cocaine and its metabolites. Int J Cardiol 1994; 46: 235–242
- Ambre J J, Belknap S M, Nelson J, et al. Acute tolerance to cocaine in humans. Clin Pharmacol Therap 1988; 44: 1–8
- Kumor K, Sherer M, Thompson L, et al. Lack of cardiovascular tolerance during intravenous cocaine infusions in human volunteers. Life Sci 1988; 42: 2063–2071
- Foltin R W, Fischman M W, Pedroso J J, Pearlson G D. Repeated intranasal cocaine administration: Lack of tolerance to pressor effects. Drug Alcohol Depend 1988; 22: 169–177